SLS - Sellas reports positive Phase 2 data from AML study files for patent
2024-05-01 10:23:01 ET
More on SELLAS Life Sciences, TG Therapeutics, etc.
- Sellas Life Sciences Group: A Lottery Ticket With An Estimated 6x Payout
- TG Therapeutics: The Cloud Over Briumvi
- TG Therapeutics: BRIUMVI Development Could Lead To Great Results
- TG Therapeutics jumps as Q1 Briumvi sales top guidance
- SELLAS Life Sciences announces IDMC's recommendation of continuing REGAL phase 3 study without modifications